Top

Published in:

Open Access 07-12-2024 | Suicide | Original Paper

The Trend in Suicide Risk Among People with HIV Before, During, and After the COVID-19 Pandemic Lockdown

Authors: Jessica Mejía-Castrejón, Yanink Caro-Vega, Juan G. Sierra-Madero, Alvaro López-Iñiguez, Brenda E. Crabtree-Ramírez

Published in: AIDS and Behavior | Issue 2/2025

Abstract

Suicide Risk (SR) and the COVID-19 pandemic affected People with HIV (PWH) disproportionately in comparison with the general population, but little information on SR during and after the COVID-19 lockdown on the Latino PWH has been described, therefore, this study aimed to describe SR in PWH attended the HIV clinic before (2018–2019), during (2020), and after (2021–2022) the COVID-19 lockdown, the trend of SR, and the factors associated. Three standardized questions from the “Columbia-Suicide Severity Rating Scale” (C-SSRS) were routinely applied as screening for suicide risk to all PWH attending their clinical visits during 2018–2022. We estimated suicidality risk and rate. We compared sociodemographic characteristics in those with and without SR. We evaluated the potential association of SR with the calendar year before, during, and after the COVID-19 lockdown using a mixed-effects logistic regression. A total of 2330 patients were seen during the study period; 2157 (93%) were evaluated for suicidality at least once, of those, 75 (3.5%) had SR. Those with SR compared with non-SR were more frequently women (20% vs 10%) and with a heterosexual HIV transmission route (29% vs 23%). SR rates per 1000 patients-day among those evaluated were 0.03 in 2018, 0.25 in 2019, 3.16 in 2020, 7.0 in 2021 and 11.98 in 2022. Throughout the model, independently of covariables, a significant increase in the OR of SR was observed in these years compared to 2018: 1.07 in 2019; 2.74 in 2021; and 4.82 in 2022, except in 2020, OR = 0.18.

Peng M. Outbreak of covid-19: An emerging global pandemic threat. Biomed Pharmacother. 2020;129: 110499. https://doi.org/10.1016/j.biopha.2020.110499.CrossRefPubMedPubMedCentral

Institute for Global Health Sciences. La respuesta de México al COVID-19: Estudio de caso. Mexico; 2021. Available from: https://globalhealthsciences.ucsf.edu/sites/globalhealthsciences.ucsf.edu/files/la_respuesta_de_mexico_al_covid_esp.pdf

Gobierno de México. Plan de gestión a largo plazo para el control de la COVID-19 . México; 2023. Secretaría de Salud. Available from https://coronavirus.gob.mx/wp-content/uploads/2023/06/2023.06.08-Plan-LP-COVID.pdf

Piret J, Boivin G. Pandemics throughout history. Front Microbiol. 2021. https://doi.org/10.3389/fmicb.2020.631736.CrossRefPubMedPubMedCentral

Dubé J, Smith M, Sherry S, Hewitt P, Stewart S. Suicide behaviors during the COVID-19 pandemic: a meta-analysis of 54 studies. Psychiatr Res. 2021;301: 113998. https://doi.org/10.1016/j.psychres.2021.113998.CrossRef

Kippe YD, Adam M, Finck A, Moran JK, Schouler-Ocak M, Bermpohl F, et al. Suicidality in psychiatric emergency department situations during the first and the second wave of covid-19 pandemic. Eur Arch Psychiatr Clin Neurosci. 2022;273(2):311–23. https://doi.org/10.1007/s00406-022-01486-6.CrossRef

Liem A, Prawira B, Magdalena S, Siandita MJ, Hudiyana J. Predicting self-harm and suicide ideation during the COVID-19 pandemic in Indonesia: a nationwide survey report. BMC Psychiatr. 2021. https://doi.org/10.31234/osf.io/f3c8w.CrossRef

Pei JH, Pei YX, Ma T, Du YH, Wang XL, Zhong JP, et al. Prevalence of suicidal ideation, suicide attempt, and suicide plan among HIV/AIDS: a systematic review and meta-analysis. J Affect Disord. 2021;292:295–304. https://doi.org/10.1016/j.jad.2021.05.064.CrossRefPubMed

Seyed Alinaghi S, Mirzapour P, Pashaei Z, Afzalian A, Tantuoyir MM, Salmani R, et al. The impacts of covid-19 pandemic on service delivery and treatment outcomes in people living with HIV: aa systematic review. AIDS Res Therapy. 2023. https://doi.org/10.1186/s12981-022-00496-7.CrossRef

10.

May D, Fullilove R. Depression, HIV, and COVID-19: a deadly trifecta. Public Health Rep. 2022;137(3):420–4. https://doi.org/10.1177/00333549221074389.CrossRefPubMedPubMedCentral

11.

Rozanova J, Rich KM, Altice FL, Shenoi SV, Zaviryukha I, Kiriazova T, et al. The initial response to covid-19 disruptions for older people with HIV in Ukraine. Geriatrics. 2022;7(6):138. https://doi.org/10.3390/geriatrics7060138.CrossRefPubMedPubMedCentral

12.

Pantelic M, Martin K, Fitzpatrick C, Nixon E, Tweed M, Spice W, et al. “I have the strength to get through this using my past experiences with HIV”: Findings from a mixed-method survey of health outcomes, service accessibility, and psychosocial wellbeing among people living with HIV during the COVID-19 pandemic. AIDS Care. 2021;34(7):821–7. https://doi.org/10.1080/09540121.2021.1975628.CrossRefPubMed

13.

Rukundo GZ, Wakida EK, Karungi CK, Asasira J, Kumakech E, Obua C. Depression, suicidality, substance-use and associated factors among people living with HIV the COVID-19 pandemic in Uganda. PLOS ONE. 2023. https://doi.org/10.1371/journal.pone.0285310.CrossRefPubMedPubMedCentral

14.

Tsai Y-T, et al. Global overview of suicidal behavior and associated risk factors among people living with human immunodeficiency virus: a scoping review. PLOS ONE. 2023. https://doi.org/10.1371/journal.pone.0269489.CrossRefPubMedPubMedCentral

15.

Bostwick JM, Pabbati C, Geske JR, McKean AJ. Suicide attempt as a risk factor for completed suicide: even more lethal than we knew. Am J Psychiatr. 2016;173(11):1094–100. https://doi.org/10.1176/appi.ajp.2016.15070854.CrossRefPubMed

16.

Large M, Corderoy A, McHugh C. Is suicidal behaviour a stronger predictor of later suicide than suicidal ideation? A systematic review and meta-analysis. Australian & New Zealand J Psychiatr. 2020. https://doi.org/10.1177/0004867420931161.CrossRef

17.

Pelton M, Ciarletta M, Wisnousky H, Lazzara N, Manglani M, Ba DM, et al. Rates and risk factors for suicidal ideation, suicide attempts and suicide deaths in persons with HIV: a systematic review and meta-analysis. General Psychiatr. 2021;34(2): e100247. https://doi.org/10.1136/gpsych-2020-100247.CrossRef

18.

Croxford S, Kitching A, Desai S, Kall M, Edelstein M, Skingsley A, et al. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort. The Lancet Public Health. 2017;2(1):e35-46. https://doi.org/10.1016/S2468-2667(16)30020-2.CrossRefPubMed

19.

Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-Suicide Severity Rating Scale: Initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatr. 2011;168(12):1266–77. https://doi.org/10.1176/appi.ajp.2011.10111704.CrossRefPubMed

20.

Al-Halabí S, Sáiz PA, Burón P, Garrido M, Benabarre A, Jiménez E, et al. Validation of a Spanish version of the Columbia-Suicide Severity Rating Scale (C-SSRS). Revista de Psiquiatría y Salud Mental (English Edition). 2016;9(3):134–42. https://doi.org/10.1016/j.rpsmen.2016.06.004.CrossRef

21.

Villarreal Sotelo K, Peña Cárdenas F, Zamorano González B, Vargas Orozco CM, Hernández Rodríguez I, Landero PC. Prevalence of suicidal behavior in a northeastern Mexican border population during the COVID-19 pandemic. Front Psychol. 2023. https://doi.org/10.3389/fpsyg.2022.984374.CrossRefPubMedPubMedCentral

22.

Alderete-Aguilar C, Cruz-Maycott R, Candela-Iglesias M, Rodríguez-Estrada E, Reyes-Terán G. Assessment of depression, anxiety, hopelessness and suicidal risk in HIV + inpatients. Salud Mental. 2017;40(1):23–8. https://doi.org/10.17711/sm.0185-3325.2017.004.CrossRef

23.

Viguera AC, Milano N, Laurel R, Thompson NR, Griffith SD, Baldessarini RJ, et al. Comparison of electronic screening for suicidal risk with the patient health questionnaire item 9 and the columbia suicide severity rating scale in an outpatient psychiatric clinic. Psychosomatics. 2015;56(5):460–9. https://doi.org/10.1016/j.psym.2015.04.005.CrossRefPubMed

24.

Lund-Sørensen H, Benros ME, Madsen T, Sørensen HJ, Eaton WW, Postolache TT, et al. A nationwide cohort study of the association between hospitalization with infection and risk of death by suicide. JAMA Psychiatr. 2016;73(9):912. https://doi.org/10.1001/jamapsychiatry.2016.1594.CrossRef

25.

Jacobson JM, Osteen P, Jones A, Berman A. Evaluation of the recognizing and responding to suicide risk training. Suicide and Life-Threatening Behav. 2012;42(5):471–85. https://doi.org/10.1111/j.1943-278x.2012.00105.x.CrossRef

26.

Fedorowicz SE, Dempsey RC, Ellis N, Phillips E, Gidlow C. How is suicide risk assessed in healthcare settings in the UK? A systematic scoping review. PLOS ONE. 2023. https://doi.org/10.1371/journal.pone.0280789.CrossRefPubMedPubMedCentral

27.

Osborne D, De Boer K, Meyer D, Nedeljkovic M. Raising suicide in medical appointments—barriers and facilitators experienced by young adults and GPS: a mixed-methods systematic review. Int J Environ Res Public Health. 2023;20(1):822. https://doi.org/10.3390/ijerph20010822.CrossRefPubMedPubMedCentral

28.

Parcesepe AM, Stockton M, Remch M, Wester CW, Bernard C, Ross J, et al. Availability of screening and treatment for common mental disorders in HIV clinic settings: Data from the Global International Epidemiology databases to evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020. J Int AIDS Soc. 2023. https://doi.org/10.1002/jia2.26147.CrossRefPubMedPubMedCentral

29.

Yan Y, Hou J, Li Q, Yu NX. Suicide before and during the covid-19 pandemic: a systematic review with meta-analysis. Int J Environ Res Public Health. 2023;20(4):3346. https://doi.org/10.3390/ijerph20043346.CrossRefPubMedPubMedCentral

30.

Pieh C, Budimir S, Humer E, Probst T. Comparing mental health during the COVID-19 lockdown and 6 months after the lockdown in Austria: a longitudinal study. Front Psych. 2021;30:12. https://doi.org/10.3389/fpsyt.2021.625973.CrossRef

31.

Richter D, Riedel-Heller S, Zürcher SJ. Mental health problems in the general population during and after the first lockdown phase due to the SARS-Cov-2 pandemic: rapid review of multi-wave studies. Epidemiol Psychiatr Sci. 2021;9(30): e27. https://doi.org/10.1017/S2045796021000160.CrossRef

32.

Martínez-Alés G, Szmulewicz A, López-Cuadrado T, Morrison CN, Keyes KM, Susser ES. Suicide following the COVID-19 pandemic Outbreak: variation across place, over time, and across sociodemographic groups. A systematic integrative review. Current Psychiatr Reports/Current Psychiatr Rep. 2023;25(7):283–300. https://doi.org/10.1007/s11920-023-01427-7.CrossRef

33.

Conejero I, Nobile B, Olié E, Courtet PH. How does covid-19 affect the neurobiology of suicide? Current Psychiatr Rep. 2021. https://doi.org/10.1007/s11920-021-01227-x.CrossRef

34.

Boukouvalas E, El-Den S, Murphy AL, Salvador-Carulla L, O’Reilly CL. Exploring health care professionals’ knowledge of, attitudes towards, and confidence in caring for people at risk of suicide: a systematic review. Arch Suicide Res. 2019. https://doi.org/10.1080/13811118.2019.1586608.CrossRefPubMed

35.

Lea AN, Levine TM, Davy-Mendez T, Leibowitz A, Altschuler A, Flamm J, et al. Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic. BMC Health Serv Res. 2023. https://doi.org/10.1186/s12913-023-09477-6.CrossRefPubMedPubMedCentral

36.

Connor J, Madhavan S, Mokashi M, Amanuel H, Johnson NR, Pace LE, et al. Health risks and outcomes that disproportionately affect women during the COVID-19 pandemic: a review. Soc Sci Med. 2020;266: 113364. https://doi.org/10.1016/j.socscimed.2020.113364.CrossRefPubMedPubMedCentral

37.

Rafiei S, Raoofi S, Pashazadeh Kan F, Masoumi M, Doustmehraban M, Biparva A, et al. Global prevalence of suicide in patients living with HIV/AIDS: a systematic review and meta-analysis. J Affect Disord. 2023;323:400–8. https://doi.org/10.1016/j.jad.2022.11.061.CrossRefPubMed

38.

Bautista-Arredondo S, Servan-Mori E, Beynon F, González A, Volkow P. A tale of two epidemics: gender differences in socio-demographic characteristics and sexual behaviors among HIV positive individuals in Mexico City. Int J Equity Health. 2015. https://doi.org/10.1186/s12939-015-0286-4.CrossRefPubMedPubMedCentral

39.

Joska JA, Andersen L, Rabie S, Marais A, Ndwandwa E-S, Wilson P, et al. Covid-19: increased risk to the mental health and safety of women living with HIV in South Africa. AIDS Behav. 2020;24(10):2751–3. https://doi.org/10.1007/s10461-020-02897-z.CrossRefPubMedPubMedCentral

40.

Bambra C. Pandemic inequalities: Emerging infectious diseases and health equity. Int J Equity Health. 2022. https://doi.org/10.1186/s12939-021-01611-2.CrossRefPubMedPubMedCentral

41.

Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN. The burden of covid-19 in people living with HIV: a syndemic perspective. AIDS Behav. 2020;24(8):2244–9. https://doi.org/10.1007/s10461-020-02871-9.CrossRefPubMedPubMedCentral

42.

May D, Fullilove R. Depression, HIV, and COVID-19: a deadly trifecta. Public Health Rep. 2022;137(3):420–4. https://doi.org/10.1177/00333549221074389.CrossRefPubMedPubMedCentral

43.

Operario D, Sun S, Bermudez AN, Masa R, Shangani S, van der Elst E, et al. Integrating HIV and mental health interventions to address a global syndemic among men who have sex with men. The Lancet HIV. 2022. https://doi.org/10.1016/s2352-3018(22)00076-5.CrossRefPubMedPubMedCentral

44.

Mezzina R, Gopikumar V, Jenkins J, Saraceno B, Sashidharan SP. Social vulnerability and mental health inequalities in the “syndemic”: Call for action. Front Psychiatr. 2022. https://doi.org/10.3389/fpsyt.2022.894370.CrossRef

45.

Remien R, Stirratt M, Nguyen N, Robbins R, Pala A, Mellins C. Mental health and HIV/AIDS. AIDS. 2019;33(9):1411–20. https://doi.org/10.1097/QAD.0000000000002227.CrossRefPubMed

46.

Patel V, Saxena S, Lund C, Thornicroft G, Baingana F, Bolton P, Chisholm D, Collins PY, Cooper JL, Eaton J, Herrman H, Herzallah MM, Huang Y, Jordans MJD, Kleinman A, Medina-Mora ME, Morgan E, Niaz U, Omigbodun O, Prince M, Rahman A, Saraceno B, Sarkar BK, De Silva M, Singh I, Stein DJ, Sunkel C, Unützer J. The lancet commission on global mental health and sustainable development. Lancet. 2018;392(10157):1553–98. https://doi.org/10.1016/S0140-6736(18)31612-X.CrossRefPubMed

47.

Okimat P, Akena D, Opio D, Mutabazi T, Sendaula E, Semitala FC, Kalyango JN, Karamagi CA. Screening PLHIV for depression using PHQs: A RCT comparing non-selective with selective screening strategy within a primary health care facility in Uganda. PLoS ONE. 2022;17(6): e0270175. https://doi.org/10.1371/journal.pone.0270175.CrossRefPubMedPubMedCentral

Title: The Trend in Suicide Risk Among People with HIV Before, During, and After the COVID-19 Pandemic Lockdown
Authors: Jessica Mejía-Castrejón
Yanink Caro-Vega
Juan G. Sierra-Madero
Alvaro López-Iñiguez
Brenda E. Crabtree-Ramírez
Publication date: 07-12-2024
Publisher: Springer US
Keywords: Suicide
Suicide
Human Immunodeficiency Virus
COVID-19
Suicidality
Published in: AIDS and Behavior / Issue 2/2025
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-024-04548-z

Effect of Mental Health Care Visits on HIV Care Outcomes

Open Access
Human Immunodeficiency Virus
Original Paper

The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study Protocol

Human Immunodeficiency Virus
Original Paper

A Qualitative Assessment of South Africa’s Central Chronic Medication Dispensing and Distribution Program for Differentiated Antiretroviral Therapy Delivery in Umlazi Township, South Africa: Client Perspectives after 12 Months of Participation

Open Access
Human Immunodeficiency Virus
Original Paper

Severity and Number of Substances Used are Independently Associated with Antiretroviral Therapy Adherence Over Time among People with HIV in the Current Treatment Era

Human Immunodeficiency Virus
Original Paper

Correction: Severity and Number of Substances Used are Independently Associated with Antiretroviral Therapy Adherence Over Time Among People with HIV in the Current Treatment Era

Acquired Immune Deficiency Syndrome
Correction

Examining the Role of Posttraumatic Stress and Depressive Symptoms in HIV Pre-exposure Prophylaxis (PrEP) Motivation Among Women Survivors of Intimate Partner Violence

Post Traumatic Stress Disorder
Original Paper

Keynote webinar | Spotlight on advances in lupus

Live
Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital

Prof. Ronald F. van Vollenhoven

Developed by: Springer Medicine

Elevate your expertise in aplastic anemia (Link opens in a new window)

Aplastic Anemia
Independent Medical Education

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases.

Supported by:

Pfizer

Developed by: Springer Healthcare IME

Learn more

Keynote webinar | Spotlight on advances in lupus

Springer Medicine

Abstract

Please log in to get access to this content